HALEOS LABS
|
The Current P/S Ratio of HALEOS LABS is 1.41.
| Share Price | ₹1,524.8 | Sep 01,2026 |
| Market Cap | ₹457.4 Cr | |
| Sales-TTM | ₹324.2 Cr | TTM-Consolidated Results |
| Price/Sales | 1.41x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of HALEOS LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹457.4 Cr] as on Sep 01,2026
(/) Sales [ ₹324.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.41x ]
Thus, for HALEOS LABS , the investors are currently willing to pay '1.41 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of HALEOS LABS !
The chart below summarizes the trend in P/S Ratio of HALEOS LABS over the last five years.
Historical PS (Price/Sales) ratio chart of HALEOS LABS
PS Ratio Performance Analysis for HALEOS LABS
- HALEOS LABS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.66x.
- HALEOS LABS 's operated at median p/e ratio of 0.6x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HALEOS LABS 's p/e ratio peaked in Mar2025 at 0.95x.
- HALEOS LABS 's p/e ratio hit its five-year low in Mar2023 of 0.5x.
How does HALEOS LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| HALEOS LABS | 324.2 | 1.41 | 457.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.73 | 463,180.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.67 | 243,302.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.00 | 188,623.0 |
| CIPLA LTD | 28,324.4 | 4.04 | 114,554.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.94 | 97,741.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.61 | 97,467.0 |
| LUPIN LTD | 29,966.6 | 3.28 | 98,312.2 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.06 | 116,114.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.77 | 96,836.1 |
| LAURUS LABS LTD | 7,269.6 | 13.82 | 100,498.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs HALEOS LABS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.41x |
| Max industry PS | 21.67x |
| Median industry PS | 4.06x |
| Average industry PS | 7.30x |
You may also like the below Video Courses